Evidence map›Paper›PMID 25810551›Full record

ArticleJournal of virology2015

Association of Kaposi's Sarcoma-Associated Herpesvirus ORF31 with ORF34 and ORF24 Is Critical for Late Gene Expression.

Kevin Brulois, Lai-Yee Wong, Hye-Ra Lee, Priyanka Sivadas, Armin Ensser, Pinghui Feng, Shou-Jiang Gao, Zsolt Toth, Jae U Jung

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Conserved CxJournal of virology · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Kevin BruloisDepartment of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
Lai-Yee WongDepartment of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
Hye-Ra LeeDepartment of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
Priyanka SivadasDepartment of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
Armin EnsserKlinische und Molekulare Virologie, Virologisches Institut, Universitätsklinikum Erlangen, Erlangen, Germany.
Pinghui FengDepartment of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
Shou-Jiang GaoDepartment of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
Zsolt TothDepartment of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA ztoth@usc.edu jaeujung@med.usc.edu.
Jae U JungDepartment of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA ztoth@usc.edu jaeujung@med.usc.edu.
University of Southern California · USUniversitätsklinikum Erlangen · DE

Funding

Cell Model for KSHV Infection and Genetic ManipulationR01CA096512 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Shou-Jiang Gao · 2003 to 2026
$7.4M
Roles of the K3 and K5 in KSHV Persistence and PathogenesisP01CA180779 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2013 to 2017
$7.3M
Molecular Basis of KSHV PathogenesisR01CA082057 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 1999 to 2016
$5.1M
Regulation of KSHV replication by N6-methyladenosine (m6A) - Diversity SupplementR01CA124332 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2007 to 2025
$5.0M
MOLECULAR BASIS FOR HERPESVIRUS SAIMIRI ONCOGENICITYR01CA031363 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 1985 to 2014
$4.9M
Role of viral BCI-2 mediated anti-apoptosis and-autophagyR01AI073099 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2007 to 2017
$4.3M
KSHV Epigenetic RegulationR01DE023926 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2013 to 2024
$4.2M
Mechanism of KSHV-induced angiogenesisR01CA132637 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2008 to 2020
$3.6M
KSHV RTA: more than viral replicationR01CA115284 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2005 to 2015
$3.1M
Proviral Roles of an Innate Immune PathwayR01DE021445 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FENG, PINGHUI · 2011 to 2017
$2.5M
TRIM9-mediated anti-viral immune pathwayR01AI116585 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OU, J.-H. JAMES · 2015 to 2019
$2.3M
HISTONE MODIFIERS IN ORAL KSHV INFECTION AND MALIGNANCIESR01DE025465 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAO, SHOU-JIANG · 2015 to 2019
$2.0M
NCI NIH HHS CA115284NCI NIH HHS CA134241NCI NIH HHS CA180779NCI NIH HHS CA31363NCI NIH HHS CA82057NCI NIH HHS P01 CA180779NCI NIH HHS R01 CA031363NCI NIH HHS R01 CA082057NCI NIH HHS R01 CA096512NCI NIH HHS R01CA096512NCI NIH HHS R01 CA115284NCI NIH HHS R01 CA124332NCI NIH HHS R01CA124332NCI NIH HHS R01 CA132637NCI NIH HHS R01CA132637NCI NIH HHS R01 CA134241NCI NIH HHS R01 CA177377NCI NIH HHS R01 CA197153NHLBI NIH HHS HL110609NHLBI NIH HHS R01 HL110609NIAID NIH HHS AI073099NIAID NIH HHS AI105909NIAID NIH HHS AI116585NIAID NIH HHS R01 AI073099NIAID NIH HHS R01 AI116585NIAID NIH HHS R21 AI105909NIAID NIH HHS R21 AI119597NIAID NIH HHS R21AI119597NIDCR NIH HHS DE023926NIDCR NIH HHS R01 DE021445NIDCR NIH HHS R01 DE023926NIDCR NIH HHS R01 DE025465
6 · The paper itself

Abstract

Transcription of herpesvirus late genes depends on several virus-encoded proteins whose function is not completely understood. Here, we identify a viral trimeric complex of Kaposi's sarcoma-associated herpesvirus (KSHV) open reading frame 31 (ORF31), ORF24, and ORF34 that is required for late gene expression but not viral DNA replication. We found that (i) ORF34 bridges the interaction between ORF31 and ORF24, (ii) the amino-terminal cysteine-rich and carboxyl-terminal basic domains of ORF31 mediate the ORF31-ORF34 interaction required for late gene expression, and (iii) a complex consisting of ORF24, ORF31, and ORF34 specifically binds to the K8.1 late promoter. Together, our results support the model that a subset of lytic viral proteins assembles into a transcriptional activator complex to induce expression of late genes.

Indexed as

Gene Expression Regulation, ViralProtein MultimerizationHerpesvirus 8, HumanHumansProtein BindingProtein Interaction MappingViral ProteinsViral Proteins

Identifiers

PMID25810551
PMCPMC4442431
OpenAlexW2084761561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.